Aclarion, Inc. (NASDAQ: ACON) shares cleared breakeven Tuesday, as the health-care technology company announced it has received a Notice of Allowance from the United States Patent and Trademark Office ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while ...

Inc trading halted, volatility trading pauseMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

Aclarion, Inc. (ACON) is up by 10 percent on Tuesday after announcing that it has secured full funding for its pivotal CLARITY trial.

Aclarion stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its ...

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company with a market capitalization of ...